Detalhe da pesquisa
1.
Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study.
Breast Cancer Res Treat
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561578
2.
Factors predicting long-term physical activity of breast cancer survivors. 5-year-follow-up of the BREX exercise intervention study.
Acta Oncol
; 61(10): 1200-1208, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881067
3.
Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Br J Cancer
; 116(2): 211-217, 2017 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27931045
4.
Proportion of women with self-reported opportunistic mammography before organized screening.
Acta Oncol
; 55(7): 865-9, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27144814
5.
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
Acta Oncol
; 55(1): 59-67, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25833330
6.
[Treatment of disseminated breast cancer]. / Levinneen rintasyövän hoito.
Duodecim
; 131(11): 1033-40, 2015.
Artigo
em Fi
| MEDLINE | ID: mdl-26245064
7.
[Adjuvant drug therapies for breast cancer]. / Rintasyövän liitännäislääkehoidot.
Duodecim
; 131(1): 23-8, 2015.
Artigo
em Fi
| MEDLINE | ID: mdl-26245052
8.
Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).
Acta Oncol
; 53(2): 186-94, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23957715
9.
A graphical LASSO analysis of global quality of life, sub scales of the EORTC QLQ-C30 instrument and depression in early breast cancer.
Sci Rep
; 12(1): 2112, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35136160
10.
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.
J Clin Oncol
; 40(10): 1051-1058, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020465
11.
Sense of Coherence as Predictor of Quality of Life in Early Breast Cancer Patients.
Anticancer Res
; 41(10): 5045-5052, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593453
12.
Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled BREX exercise study.
Breast
; 59: 110-116, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225091
13.
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial.
Lancet Oncol
; 10(12): 1145-51, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19906561
14.
Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review.
Rheumatol Adv Pract
; 4(1): rkaa004, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128475
15.
Excess mortality from breast cancer in female breast cancer patients with severe mental illness.
Psychiatry Res
; 286: 112801, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001004
16.
Effectiveness of a 12-month Exercise Intervention on Physical Activity and Quality of Life of Breast Cancer Survivors; Five-year Results of the BREX-study.
In Vivo
; 33(3): 881-888, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028212
17.
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.
JAMA Oncol
; 4(9): 1199-1206, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29852043
18.
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.
JAMA Oncol
; 3(6): 793-800, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28253390
19.
Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.
Anticancer Res
; 25(3c): 2535-42, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16080489
20.
Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat.
Mol Cancer Ther
; 1(10): 869-76, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12492120